JP2011515407A5 - - Google Patents

Download PDF

Info

Publication number
JP2011515407A5
JP2011515407A5 JP2011500898A JP2011500898A JP2011515407A5 JP 2011515407 A5 JP2011515407 A5 JP 2011515407A5 JP 2011500898 A JP2011500898 A JP 2011500898A JP 2011500898 A JP2011500898 A JP 2011500898A JP 2011515407 A5 JP2011515407 A5 JP 2011515407A5
Authority
JP
Japan
Prior art keywords
mir
activity
expression
agonist
therapeutic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011500898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011515407A (ja
JP5653899B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/037405 external-priority patent/WO2009117418A2/en
Publication of JP2011515407A publication Critical patent/JP2011515407A/ja
Publication of JP2011515407A5 publication Critical patent/JP2011515407A5/ja
Application granted granted Critical
Publication of JP5653899B2 publication Critical patent/JP5653899B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011500898A 2008-03-17 2009-03-17 神経筋シナプスの維持および再生に関与するマイクロrnaの同定 Expired - Fee Related JP5653899B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3726008P 2008-03-17 2008-03-17
US61/037,260 2008-03-17
PCT/US2009/037405 WO2009117418A2 (en) 2008-03-17 2009-03-17 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014157799A Division JP5922721B2 (ja) 2008-03-17 2014-08-01 神経筋シナプスの維持および再生に関与するマイクロrnaの同定

Publications (3)

Publication Number Publication Date
JP2011515407A JP2011515407A (ja) 2011-05-19
JP2011515407A5 true JP2011515407A5 (https=) 2012-05-10
JP5653899B2 JP5653899B2 (ja) 2015-01-14

Family

ID=41091497

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011500898A Expired - Fee Related JP5653899B2 (ja) 2008-03-17 2009-03-17 神経筋シナプスの維持および再生に関与するマイクロrnaの同定
JP2014157799A Active JP5922721B2 (ja) 2008-03-17 2014-08-01 神経筋シナプスの維持および再生に関与するマイクロrnaの同定

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014157799A Active JP5922721B2 (ja) 2008-03-17 2014-08-01 神経筋シナプスの維持および再生に関与するマイクロrnaの同定

Country Status (6)

Country Link
US (2) US8202848B2 (https=)
EP (1) EP2265291B1 (https=)
JP (2) JP5653899B2 (https=)
CN (1) CN102036689B (https=)
CA (1) CA2718520C (https=)
WO (1) WO2009117418A2 (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2718520C (en) * 2008-03-17 2020-01-07 The Board Of Regents Of The University Of Texas System Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
US8734759B2 (en) * 2008-12-05 2014-05-27 Yeda Research And Development Co. Ltd. Methods of diagnosing and treating motor neuron diseases
US9276336B2 (en) 2009-05-28 2016-03-01 Hsio Technologies, Llc Metalized pad to electrical contact interface
WO2010138493A1 (en) 2009-05-28 2010-12-02 Hsio Technologies, Llc High performance surface mount electrical interconnect
US9196980B2 (en) 2009-06-02 2015-11-24 Hsio Technologies, Llc High performance surface mount electrical interconnect with external biased normal force loading
US9184527B2 (en) 2009-06-02 2015-11-10 Hsio Technologies, Llc Electrical connector insulator housing
US8789272B2 (en) 2009-06-02 2014-07-29 Hsio Technologies, Llc Method of making a compliant printed circuit peripheral lead semiconductor test socket
US9613841B2 (en) 2009-06-02 2017-04-04 Hsio Technologies, Llc Area array semiconductor device package interconnect structure with optional package-to-package or flexible circuit to package connection
WO2010141266A1 (en) 2009-06-02 2010-12-09 Hsio Technologies, Llc Compliant printed circuit peripheral lead semiconductor package
WO2010141311A1 (en) 2009-06-02 2010-12-09 Hsio Technologies, Llc Compliant printed circuit area array semiconductor device package
US9136196B2 (en) 2009-06-02 2015-09-15 Hsio Technologies, Llc Compliant printed circuit wafer level semiconductor package
US8928344B2 (en) 2009-06-02 2015-01-06 Hsio Technologies, Llc Compliant printed circuit socket diagnostic tool
WO2010141298A1 (en) 2009-06-02 2010-12-09 Hsio Technologies, Llc Composite polymer-metal electrical contacts
US8912812B2 (en) 2009-06-02 2014-12-16 Hsio Technologies, Llc Compliant printed circuit wafer probe diagnostic tool
WO2010147934A1 (en) 2009-06-16 2010-12-23 Hsio Technologies, Llc Semiconductor die terminal
WO2012074963A1 (en) 2010-12-01 2012-06-07 Hsio Technologies, Llc High performance surface mount electrical interconnect
US8987886B2 (en) 2009-06-02 2015-03-24 Hsio Technologies, Llc Copper pillar full metal via electrical circuit structure
US8988093B2 (en) 2009-06-02 2015-03-24 Hsio Technologies, Llc Bumped semiconductor wafer or die level electrical interconnect
WO2010141264A1 (en) 2009-06-03 2010-12-09 Hsio Technologies, Llc Compliant wafer level probe assembly
WO2010141295A1 (en) 2009-06-02 2010-12-09 Hsio Technologies, Llc Compliant printed flexible circuit
US9320144B2 (en) 2009-06-17 2016-04-19 Hsio Technologies, Llc Method of forming a semiconductor socket
US8984748B2 (en) 2009-06-29 2015-03-24 Hsio Technologies, Llc Singulated semiconductor device separable electrical interconnect
US20110293653A1 (en) * 2010-03-11 2011-12-01 University Of Massachusetts Antagonists of mir-155 for the treatment of inflammatory liver disease
US8758067B2 (en) 2010-06-03 2014-06-24 Hsio Technologies, Llc Selective metalization of electrical connector or socket housing
KR101235256B1 (ko) * 2010-09-13 2013-02-21 서울대학교산학협력단 miRNA를 타겟으로 한 신경퇴행성 질환 치료
CA2851280C (en) 2011-10-11 2021-05-18 The Brigham And Women's Hospital, Inc. Micrornas in neurodegenerative disorders
JP6340366B2 (ja) 2012-07-31 2018-06-06 イェダ リサーチ アンド デベロップメント カンパニー リミテッド 運動ニューロン疾患を診断および処置する方法
CA2902571A1 (en) 2013-03-15 2014-09-18 MiRagen Therapeutics, Inc. Bridged bicyclic nucleosides
KR101566586B1 (ko) * 2013-08-21 2015-11-16 서울대학교산학협력단 miRNA를 표적으로 하는 뇌전증 또는 발작 관련 질환의 예방 또는 치료용 약학 조성물 및 방법
WO2016157175A1 (en) 2015-03-27 2016-10-06 Yeda Research And Development Co. Ltd. Methods of treating motor neuron diseases
JP6666002B2 (ja) * 2015-10-07 2020-03-13 国立大学法人京都大学 Tdp−43プロテノパシーの予防又は治療用組成物
KR102177130B1 (ko) 2017-08-18 2020-11-10 (주)큐라미스 근육 질환 및 신경근육 질환 예방, 치료 또는 진단을 위한 miR-18b의 용도
WO2019195304A1 (en) 2018-04-03 2019-10-10 Academia Sinica Mir-17~92 as therapeutic or diagnostic target of motor neuron (mn) degeneration diseases
CN108690846A (zh) * 2018-04-17 2018-10-23 上海大学 抑制MiR-29b基因表达的应用
CN110538192A (zh) * 2018-05-29 2019-12-06 中国科学院深圳先进技术研究院 一种HDAC4信号通路miRNA抑制剂及其过表达方法和应用
CN110468202A (zh) * 2019-01-18 2019-11-19 宁夏医科大学 一种靶向TIGIT的miR-206作为肝癌诊断和治疗新型分子的用途
US10844380B1 (en) 2019-06-17 2020-11-24 Biorchestra Co., Ltd. Uses for prevention or treatment of brain diseases using microrna
US11198908B2 (en) 2019-06-17 2021-12-14 Biorchestra Co., Ltd. Method for diagnosis of Alzheimer's disease using microRNA
JP2024506869A (ja) * 2021-02-05 2024-02-15 バイオーケストラ カンパニー, リミテッド Nlrp3発現の異常に関連する疾患または障害を治療するためのmirna-485阻害剤の使用
CN116981484A (zh) * 2021-02-05 2023-10-31 生物欧赛加有限责任公司 miRNA-485抑制剂调控PSD95、突触素和半胱天冬酶3表达的用途

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
EP0273085A1 (en) 1986-12-29 1988-07-06 IntraCel Corporation A method for internalizing nucleic acids into eukaryotic cells
US6867195B1 (en) 1989-03-21 2005-03-15 Vical Incorporated Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
TW215434B (https=) 1992-03-07 1993-11-01 Hoechst Ag
JP4285766B2 (ja) 1994-03-23 2009-06-24 オハイオ ユニバーシティ 緻密にした核酸および細胞へのデリバリ
US5972901A (en) 1994-03-23 1999-10-26 Case Western Reserve University Serpin enzyme complex receptor--mediated gene transfer
US6077835A (en) 1994-03-23 2000-06-20 Case Western Reserve University Delivery of compacted nucleic acid to cells
US5844107A (en) 1994-03-23 1998-12-01 Case Western Reserve University Compacted nucleic acids and their delivery to cells
US6040296A (en) 1995-06-07 2000-03-21 East Carolina University Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
US7034007B1 (en) 1995-06-07 2006-04-25 East Carolina University Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) & surfactant depletion
US6825174B2 (en) 1995-06-07 2004-11-30 East Carolina University Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
US6025339A (en) 1995-06-07 2000-02-15 East Carolina University Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation
US5994315A (en) 1995-06-07 1999-11-30 East Carolina University Low adenosine agent, composition, kit and method for treatment of airway disease
WO1999013886A1 (en) 1997-09-17 1999-03-25 East Carolina University Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications
EP1011608A4 (en) 1998-06-08 2002-05-15 Epigenesis Pharmaceuticals Inc COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF HEART AND NEUTRAL FAILURE OR DAMAGE RELATED TO ISCHEMIA, ENDOTOXIN RELEASE, ARDS OR CALLED BY THE ADDITION OF SPECIFIC MEDICINES
US20050014711A1 (en) 1998-06-09 2005-01-20 Nyce Jonathan W. Composition, formulations & methods for prevention and treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) and inflammation
US20020042388A1 (en) 2001-05-01 2002-04-11 Cooper Mark J. Lyophilizable and enhanced compacted nucleic acids
WO2002032396A2 (en) 2000-10-16 2002-04-25 Massachusetts Institute Of Technology Lipid-protein-sugar particles for delivery of nucleic acids
US20040259247A1 (en) * 2000-12-01 2004-12-23 Thomas Tuschl Rna interference mediating small rna molecules
JP2004535388A (ja) 2001-04-30 2004-11-25 ターゲティッド ジェネティクス コーポレイション 脂質含有薬物送達複合体およびそれらの生成方法
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
EP2390331B1 (en) 2001-09-28 2018-04-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. MicroRNA molecules
US7851150B2 (en) 2002-12-18 2010-12-14 Third Wave Technologies, Inc. Detection of small nucleic acids
CA2941594C (en) 2002-12-20 2021-07-06 Celera Corporation Genetic polymorphisms of the protein receptor c (procr) associated with myocardial infarction, methods of detection and uses thereof
JP2006519008A (ja) 2003-02-10 2006-08-24 独立行政法人産業技術総合研究所 哺乳動物細胞の調節
US7750144B2 (en) 2003-06-02 2010-07-06 University Of Massachusetts Methods and compositions for enhancing the efficacy and specificity of RNA silencing
US7683036B2 (en) 2003-07-31 2010-03-23 Regulus Therapeutics Inc. Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
US7776569B2 (en) 2003-08-22 2010-08-17 University Of Massachusetts Virally-encoded RNAs as substrates, inhibitors and delivery vehicles for RNAi
US20080045417A1 (en) 2003-10-14 2008-02-21 Jan Weiler Oligonucleotide Microarray
EP2295604B1 (en) * 2004-02-09 2015-04-08 Thomas Jefferson University Diagnosis and treatment of cancers with microRNA located in or near cancer-associated chromosomal features
US20050182005A1 (en) * 2004-02-13 2005-08-18 Tuschl Thomas H. Anti-microRNA oligonucleotide molecules
EP1723162A4 (en) 2004-02-13 2010-05-05 Univ Rockefeller ANTI-microRNA oligonucleotide molecules
US20070258949A1 (en) 2004-03-01 2007-11-08 Five Prime Therapeutics, Inc. Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use
US20050260648A1 (en) 2004-04-06 2005-11-24 Huffel Christophe V Method for the determination of cellular transcriptional
US20060134639A1 (en) 2004-04-06 2006-06-22 Huffel Christophe V Method for the determination of cellular transcriptional regulation
CN101056991A (zh) 2004-04-20 2007-10-17 基因耐克生物医学制品有限公司 检测ncRNA的方法
AU2005243187A1 (en) 2004-05-11 2005-11-24 Wyeth Oligonucleotide arrays to monitor gene expression and methods for making and using same
CA2566519C (en) 2004-05-14 2020-04-21 Rosetta Genomics Ltd. Micrornas and uses thereof
EP2290071B1 (en) * 2004-05-28 2014-12-31 Asuragen, Inc. Methods and compositions involving microRNA
US7575863B2 (en) 2004-05-28 2009-08-18 Applied Biosystems, Llc Methods, compositions, and kits comprising linker probes for quantifying polynucleotides
US7635563B2 (en) 2004-06-30 2009-12-22 Massachusetts Institute Of Technology High throughput methods relating to microRNA expression analysis
WO2006047454A2 (en) 2004-10-21 2006-05-04 Rutgers, The State University Of New Jersey Rational probe optimization for detection of micrornas
CA2857881A1 (en) 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
US20060185027A1 (en) 2004-12-23 2006-08-17 David Bartel Systems and methods for identifying miRNA targets and for altering miRNA and target expression
WO2006069584A2 (en) 2004-12-29 2006-07-06 Exiqon A/S NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs
US20090123912A1 (en) 2005-01-25 2009-05-14 Rosetta Inpharmatics Llc Methods for quantitating small RNA molecules
GB0502042D0 (en) * 2005-02-01 2005-03-09 Univ Glasgow Materials and methods for diagnosis and treatment of chronic fatigue syndrome
US20070065840A1 (en) 2005-03-23 2007-03-22 Irena Naguibneva Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
WO2006107826A2 (en) 2005-04-04 2006-10-12 The Board Of Regents Of The University Of Texas System Micro-rna's that regulate muscle cells
JP2006292367A (ja) 2005-04-05 2006-10-26 Mitsubishi Rayon Co Ltd miRNA検出用マイクロアレイ
EP1874936B1 (en) 2005-04-19 2013-10-30 BASF Plant Science GmbH Improved methods controlling gene expression
EP2631292A3 (en) 2005-04-29 2013-11-20 The Rockefeller University Human microRNAs and methods for inhibiting same
US20060265771A1 (en) 2005-05-17 2006-11-23 Lewis David L Monitoring microrna expression and function
PL2002003T3 (pl) 2005-05-27 2016-06-30 Ospedale San Raffaele Srl Wektor genetyczny zawierający mi-RNA
WO2006133022A2 (en) 2005-06-03 2006-12-14 The Johns Hopkins University Compositions and methods for decreasing microrna expression for the treatment of neoplasia
US20070065844A1 (en) 2005-06-08 2007-03-22 Massachusetts Institute Of Technology Solution-based methods for RNA expression profiling
WO2007002375A2 (en) 2005-06-23 2007-01-04 U.S. Genomics, Inc. Methods and compositions for analysis of microrna
US20070003939A1 (en) 2005-07-01 2007-01-04 Hui Wang Melting temperature matching
JP5489459B2 (ja) 2005-08-01 2014-05-14 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 乳癌の診断、予後及び治療のためのマイクロrnaに基づいた方法及び組成物
US20070054872A1 (en) 2005-08-24 2007-03-08 Mirus Bio Corporation Regulatable or conditional expression systems
WO2007028030A2 (en) 2005-09-02 2007-03-08 Picobella, Llc Oncogenic regulatory rnas for diagnostics and therapeutics
CA2845251A1 (en) 2005-09-12 2007-03-22 The Ohio State University Research Foundation Compositions for the therapy of bcl2-associated cancers and methods of preparation thereof
WO2007042899A2 (en) 2005-10-10 2007-04-19 Council Of Scientific And Industrial Research Human microrna targets in hiv genome and a method of identification thereof
US20070092882A1 (en) 2005-10-21 2007-04-26 Hui Wang Analysis of microRNA
PL1969125T3 (pl) * 2005-12-12 2012-11-30 Univ North Carolina Chapel Hill Mikrorna, które regulują proliferację i różnicowanie komórek mięśniowych
US7390792B2 (en) 2005-12-15 2008-06-24 Board Of Regents, The University Of Texas System MicroRNA1 therapies
EP1966390A1 (en) 2005-12-29 2008-09-10 Exiqon A/S Detection of tissue origin of cancer
JP5490413B2 (ja) 2006-01-05 2014-05-14 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション 膵内分泌腫瘍及び膵腺房腫瘍におけるマイクロrna発現異常
WO2007081196A1 (en) 2006-01-10 2007-07-19 Koninklijke Nederlandse Akademie Van Wetenschappen New nucleic acid molecules and collections thereof, their application and identification
ES2448491T3 (es) 2006-03-02 2014-03-14 The Ohio State University Research Foundation Perfil de expresión de microARN asociado con cáncer de páncreas
CA2648132C (en) 2006-04-03 2019-05-28 Santaris Pharma A/S Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
GB2440782A (en) 2006-08-04 2008-02-13 Cesare Peschle Uses and compositions comprising miRNAs
US20090306181A1 (en) 2006-09-29 2009-12-10 Children's Medical Center Corporation Compositions and methods for evaluating and treating heart failure
EP2489742A1 (de) 2006-10-09 2012-08-22 Julius-Maximilians-Universität Würzburg MicroRNA (MIRNA) zur Diagnose und Therapie von Herzerkrankungen
WO2008147430A2 (en) 2006-10-11 2008-12-04 Nucleonics, Inc. Microrna-formatted multitarget interfering rna vector constructs and methods of using the same
US20100021914A1 (en) 2006-11-23 2010-01-28 Querdenker Aps Oligonucleotides for modulating target rna activity
US8258286B2 (en) 2007-04-26 2012-09-04 University Of Iowa Research Foundation Reduction of off-target RNA interference toxicity
US20090005336A1 (en) 2007-05-08 2009-01-01 Zhiguo Wang Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
WO2008147839A1 (en) 2007-05-23 2008-12-04 Dharmacon, Inc. Micro-rna scaffolds and non-naturally occurring micro-rnas
US20090004668A1 (en) * 2007-06-22 2009-01-01 The Board Of Trustees Of The Leland Stanford Junior University Pre-miRNA loop-modulated target regulation
US20090092980A1 (en) 2007-07-20 2009-04-09 Christoph Arenz miRNA PROCESSING INHIBITOR EFFICACY ASSAYS AND SUBSTANCES
US20100292099A1 (en) 2007-08-23 2010-11-18 Keren Pharmaceutical, Inc. Targeting of rna with external guide sequences
EP2623599B1 (en) 2007-10-04 2019-01-02 Roche Innovation Center Copenhagen A/S Micromirs
CN101424640B (zh) 2007-11-02 2012-07-25 江苏命码生物科技有限公司 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法
US20090186414A1 (en) 2008-01-18 2009-07-23 Deepak Srivastava Methods of Generating Cardiomyocytes and Cardiac Progenitors and Compositions
US8188060B2 (en) 2008-02-11 2012-05-29 Dharmacon, Inc. Duplex oligonucleotides with enhanced functionality in gene regulation
WO2009111375A2 (en) 2008-03-01 2009-09-11 Abraxis Bioscience, Llc Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
EP2268811A1 (en) 2008-03-07 2011-01-05 Santaris Pharma A/S Pharmaceutical compositions for treatment of microrna related diseases
CA2718520C (en) * 2008-03-17 2020-01-07 The Board Of Regents Of The University Of Texas System Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
EP2105145A1 (en) 2008-03-27 2009-09-30 ETH Zürich Method for muscle-specific delivery lipid-conjugated oligonucleotides
US8916532B2 (en) 2008-04-28 2014-12-23 The Trustees Of The University Of Pennsylvania Methods for enhancing utrophin production via inhibition of microRNA
CA2726052A1 (en) 2008-06-04 2009-12-10 The Board Of Regents Of The University Of Texas System Modulation of gene expression through endogenous small rna targeting of gene promoters
AU2009257663B2 (en) 2008-06-09 2014-06-26 New York Medical College Compositions comprising cardiac stem cells overexpressing specific microRNA and methods of their use in repairing damaged myocardium
EP2169059A1 (en) 2008-09-25 2010-03-31 Academisch Medisch Centrum bij de Universiteit van Amsterdam Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis
EP2358398A2 (en) 2008-10-24 2011-08-24 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
AU2009336191B2 (en) 2008-12-18 2017-08-24 Novo Nordisk A/S Extended dicer substrate agents and methods for the specific inhibition of gene expression
US20100173973A1 (en) 2008-12-18 2010-07-08 Dicerna Pharmaceuticals, Inc. Extended dicer substrate agents and methods for the specific inhibition of gene expression

Similar Documents

Publication Publication Date Title
JP2011515407A5 (https=)
US20230255915A1 (en) L-dopa microbiome therapy
Rohm et al. Energy metabolism in cachexia
Izumi et al. Effects of metoprolol on epinephrine-induced takotsubo-like left ventricular dysfunction in non-human primates
AU2013323820B2 (en) Peptide-linked morpholino antisense oligonucleotides for treatment of myotonic dystrophy
JP6035326B2 (ja) アルツハイマー病、ハンチントン病、自閉症及びその他の疾患を治療する方法
Naveilhan et al. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system
CN114615998B (zh) 缀合物及其用途
KR20160042039A (ko) 인산염 수송을 억제하기 위한 화합물 및 방법
JP2013176369A (ja) β1−アドレナリン作動性レセプター抗体を阻害する変異体二重環化レセプターペプチド
WO2013160317A2 (en) Crhr1 antagonists for use in the treatment of patients having crh overactivity
JP2015522264A5 (https=)
JP2013524792A5 (https=)
US20250262329A1 (en) Treatment of heart disease by disruption of the anchoring of pp2a
Yang et al. Exploring the competence stimulating peptide (CSP) N-terminal requirements for effective ComD receptor activation in group1 Streptococcus pneumoniae
US20190160050A1 (en) Small molecule inhibition for preventing or treating fibrotic diseases
Theilen et al. TFAM overexpression diminishes skeletal muscle atrophy after hindlimb suspension in mice
Jung et al. MicroRNA‑mediated regulation of muscular atrophy: Exploring molecular pathways and therapeutics
Kim et al. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy
Seow et al. Identification of a novel muscle targeting peptide in mdx mice
CA2693141C (en) Use of a granulin or a granulin-like compound in the therapy or prophylaxis of neuropathic pain
IGARASHI et al. Effect of calcimimetic agent, KRN568, on gastrin secretion in healthy subjects
CN112915196B (zh) Creg1蛋白用于预防或治疗索拉非尼诱导的心肌损伤的医药用途
EP3368035B1 (en) Lpa level reduction for treating central nervous system disorders
EP4203988A2 (en) Peptide inhibitors of nf kappa b and use thereof in treatment of covid-19 and inflammatory diseases